You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
We are now working on Nanoseq in a monkey. Human and mouse chromosomes usually start with N. But, in this monkey, some chromosomes start with ATGC. When sequence reads are mapped to the end of such chromosomes, errors happen at the dsa step. To avoid this problem, we remove reads at the ends of the chromosome. Could this removal affect the final mutation burden rate or other results?
The text was updated successfully, but these errors were encountered:
----------------------------------------------------------------------
The Wellcome Sanger Institute is operated by Genome Research Limited, a charity registered in England with number 1021457 and a company registered in England with number 2742969, whose registered office is Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA.
We are now working on Nanoseq in a monkey. Human and mouse chromosomes usually start with N. But, in this monkey, some chromosomes start with ATGC. When sequence reads are mapped to the end of such chromosomes, errors happen at the dsa step. To avoid this problem, we remove reads at the ends of the chromosome. Could this removal affect the final mutation burden rate or other results?
The text was updated successfully, but these errors were encountered: